New Key Statistics Module, Z-Score and F-Score
SZSE:300791 Key Ratios
Market Cap ¥ M | 6,568.66 |
Enterprise Value ¥ M | 7,561.18 |
P/E(ttm) | 20.73 |
PE Ratio without NRI | 18.10 |
Forward PE Ratio | -- |
Price/Book | 2.71 |
Price/Sales | 1.76 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | 306.45 |
Payout Ratio % | 0.18 |
Revenue (TTM) ¥ M | 3,831.00 |
EPS (TTM) ¥ | 1.74 |
Beneish M-Score | -2 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 9.30 |
y-y EBITDA Growth Rate % | 32.50 |
EV-to-EBIT | 18.75 |
EV-to-EBITDA | 18.75 |
PEG | 1.95 |
Shares Outstanding M | 181.81 |
Net Margin (%) | 8.21 |
Operating Margin % | 11.82 |
Pre-tax Margin (%) | 8.29 |
Quick Ratio | 2.20 |
Current Ratio | 3.02 |
ROA % (ttm) | 6.38 |
ROE % (ttm) | 11.98 |
ROIC % (ttm) | 10.32 |
Dividend Yield % | 0.95 |
Altman Z-Score | 3.27 |
SZSE:300791 Number of Guru Trades
SZSE:300791 Volume of Guru Trades
Gurus Latest Trades with SZSE:300791
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:300791 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Sirio Pharma Co Ltd Insider Transactions
No Available Data